Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction - PubMed (original) (raw)
Comparative Study
doi: 10.1161/CIRCIMAGING.113.000633. Epub 2013 Sep 13.
Beatrice A Marzluf, Caroline Tufaro, Stefan Pfaffenberger, Alexandra Graf, Paul Wexberg, Adelheid Panzenböck, Johannes Jakowitsch, Christine Bangert, Daniela Laimer, Catharina Schreiber, Gültekin Karakus, Martin Hülsmann, Richard Pacher, Irene M Lang, Gerald Maurer, Diana Bonderman
Affiliations
- PMID: 24036385
- DOI: 10.1161/CIRCIMAGING.113.000633
Comparative Study
Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction
Julia Mascherbauer et al. Circ Cardiovasc Imaging. 2013 Nov.
Abstract
Background: The underlying pathophysiology of heart failure with preserved ejection fraction (HFPEF) is incompletely understood, but myocardial extracellular matrix accumulation is thought to play a major role. Our aims were to estimate myocardial extracellular matrix using cardiac magnetic resonance T1 mapping and to assess the relationship between pathobiology/pathophysiology and prognosis.
Methods and results: Patients with suspected HFPEF (n=100) were enrolled in this prospective, observational study. Confirmatory diagnostic tests, cardiac magnetic resonance imaging including T1 mapping, and invasive hemodynamic assessments were performed at baseline. Sixty-one patients with confirmed HFPEF entered a longitudinal outcome-monitoring phase (mean, 22.9±5.0 months), during which 16 had a cardiac event. Cardiac magnetic resonance T1 time (hazard ratio, 0.99; 95% confidence interval, 0.98-0.99; P=0.046), left atrial area (hazard ratio, 1.08; 95% confidence interval, 1.03-1.13; P<0.01), and pulmonary vascular resistance (hazard ratio, 1.01; 95% confidence interval, 1.00-1.01; P=0.03) were significantly associated with cardiac events. Patients with T1 times below the median (<388.3 ms) were at greater risk of cardiac events than the rest of the group (P<0.01). Extracellular matrix of left ventricular biopsies (n=9), quantified by TissueFAXS technology correlated with T1 time (R=0.98; P<0.01). T1 time also correlated with right ventricular-pulmonary arterial coupling (pulmonary vascular resistance: R=-0.36; P<0.01; right ventricular ejection fraction: R=0.28; P=0.01).
Conclusions: In the present preliminary study, cardiac magnetic resonance postcontrast T1 time is associated with prognosis in HFPEF, suggesting postcontrast T1 as possible biomarker for HFPEF.
Keywords: hypertension, pulmonary; magnetic resonance imaging; prognosis.
Comment in
- T1 mapping in heart failure: from technique to prognosis, toward altering outcome.
Baksi AJ, Pennell DJ. Baksi AJ, et al. Circ Cardiovasc Imaging. 2013 Nov;6(6):861-3. doi: 10.1161/CIRCIMAGING.113.001178. Circ Cardiovasc Imaging. 2013. PMID: 24254477 No abstract available. - Letter by Barison et al regarding article, "Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction".
Barison A, Aquaro GD, Masci PG. Barison A, et al. Circ Cardiovasc Imaging. 2014 Mar;7(2):414. doi: 10.1161/CIRCIMAGING.113.001598. Circ Cardiovasc Imaging. 2014. PMID: 24642926 No abstract available.
Similar articles
- Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
Patel RB, Li E, Benefield BC, Swat SA, Polsinelli VB, Carr JC, Shah SJ, Markl M, Collins JD, Freed BH. Patel RB, et al. ESC Heart Fail. 2020 Feb;7(1):253-263. doi: 10.1002/ehf2.12565. Epub 2020 Jan 5. ESC Heart Fail. 2020. PMID: 31903694 Free PMC article. - Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Kanagala P, Cheng ASH, Singh A, Khan JN, Gulsin GS, Patel P, Gupta P, Arnold JR, Squire IB, Ng LL, McCann GP. Kanagala P, et al. JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 2):2291-2301. doi: 10.1016/j.jcmg.2018.11.031. Epub 2019 Feb 13. JACC Cardiovasc Imaging. 2019. PMID: 30772227 - Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
Duca F, Kammerlander AA, Zotter-Tufaro C, Aschauer S, Schwaiger ML, Marzluf BA, Bonderman D, Mascherbauer J. Duca F, et al. Circ Cardiovasc Imaging. 2016 Dec;9(12):e005277. doi: 10.1161/CIRCIMAGING.116.005277. Circ Cardiovasc Imaging. 2016. PMID: 27974408 - Is cardiac resynchronization therapy an option in heart failure patients with preserved ejection fraction? Justification for the ongoing KaRen project.
Donal E, Lund L, Linde C, Daubert JC; KaRen investigators. Donal E, et al. Arch Cardiovasc Dis. 2010 Jun-Jul;103(6-7):404-10. doi: 10.1016/j.acvd.2010.01.009. Epub 2010 Jun 23. Arch Cardiovasc Dis. 2010. PMID: 20800804 Review. - The Emerging Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Patients with HFpEF.
Webb J, Fovargue L, Tøndel K, Porter B, Sieniewicz B, Gould J, Rinaldi CA, Ismail T, Chiribiri A, Carr-White G. Webb J, et al. Curr Heart Fail Rep. 2018 Feb;15(1):1-9. doi: 10.1007/s11897-018-0372-1. Curr Heart Fail Rep. 2018. PMID: 29404975 Free PMC article. Review.
Cited by
- The effects of dipeptidyl peptidase-4 inhibitors on cardiac structure and function using cardiac magnetic resonance: a meta-analysis of clinical studies.
Wang H, Guo S, Gu S, Li C, Wang F, Zhao J. Wang H, et al. Front Endocrinol (Lausanne). 2024 Sep 11;15:1428160. doi: 10.3389/fendo.2024.1428160. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39324124 Free PMC article. - CMR to characterize myocardial structure and function in heart failure with preserved left ventricular ejection fraction.
Ipek R, Holland J, Cramer M, Rider O. Ipek R, et al. Eur Heart J Cardiovasc Imaging. 2024 Oct 30;25(11):1491-1504. doi: 10.1093/ehjci/jeae224. Eur Heart J Cardiovasc Imaging. 2024. PMID: 39205602 Free PMC article. Review. - Cardiac MRI in heart failure with preserved ejection fraction.
Meduri A, Perazzolo A, Marano R, Muciaccia M, Lauriero F, Rovere G, Giarletta L, Moliterno E, Natale L. Meduri A, et al. Radiol Med. 2024 Oct;129(10):1468-1484. doi: 10.1007/s11547-024-01874-z. Epub 2024 Aug 19. Radiol Med. 2024. PMID: 39158816 Review. - Radiomics features of the cardiac blood pool to indicate hemodynamic changes in pulmonary hypertension (PH) due to heart failure with preserved ejection fraction (PH-HFpEF).
Lin K, Sarnari R, Gordon DZ, Markl M, Carr JC. Lin K, et al. Int J Cardiovasc Imaging. 2024 Jul;40(7):1501-1509. doi: 10.1007/s10554-024-03131-w. Epub 2024 May 27. Int J Cardiovasc Imaging. 2024. PMID: 38801547 - A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function.
Ameri P, Mercurio V, Pollesello P, Anker MS, Backs J, Bayes-Genis A, Borlaug BA, Burkhoff D, Caravita S, Chan SY, de Man F, Giannakoulas G, González A, Guazzi M, Hassoun PM, Hemnes AR, Maack C, Madden B, Melenovsky V, Müller OJ, Papp Z, Pullamsetti SS, Rainer PP, Redfield MM, Rich S, Schiattarella GG, Skaara H, Stellos K, Tedford RJ, Thum T, Vachiery JL, van der Meer P, Van Linthout S, Pruszczyk P, Seferovic P, Coats AJS, Metra M, Rosano G, Rosenkranz S, Tocchetti CG. Ameri P, et al. Eur J Heart Fail. 2024 Apr;26(4):707-729. doi: 10.1002/ejhf.3236. Epub 2024 Apr 19. Eur J Heart Fail. 2024. PMID: 38639017 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical